Skip to main content

Table 1 IC50 values [μM] for the drugs included in the cytotoxicity analyses in the LC cell line panel

From: Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells

 

NCI-H23

NCI-H157

U-1752

U-1810

U-1906-L

U-2020

b-AP15

0.41

0.52

1.6

0.32

0.50

2.8

Bortezomib

0.018

0.012

0.057

0.088

0.083

0.036

Cisplatin

3.8

26

7.3

6.3

5.5

34

Gefitinib

270

130

> 310*

73

181

54

Gemcitabine

0.29

120

155

2.2

0.35

0.60

Vinorelbine

0.0032

0.041

4.2

0.007

0.0054

5.4

  1. * Not determinable due to that the IC50 value was far above the tested concentration interval